← FDA Drug Approvals (Drugs@FDA)

APREMILAST

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: MANKIND PHARMA · Approved 2024-02-07

Drug application

FDA Application #

ANDA211734

Application type

Abbreviated New Drug Application (Generic)

Brand name

APREMILAST

Generic name

Apremilast

Active ingredients

APREMILAST

Dosage form

TABLET

Route

ORAL

Marketing status

Prescription

Sponsor

MANKIND PHARMA

First approval

2024-02-07

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown